Potent anti-diabetic effects of MHY908, a newly synthesized PPAR α/γ dual agonist in db/db mice.
Peroxisome proliferator-activated receptor (PPAR) α/γ dual agonists have been developed to alleviate metabolic disorders and have the potential to be used as therapeutic agents for the treatment of type 2 diabetes. In this study, we investigated the effects of a newly synthesized PPAR α/γ dual agoni...
Saved in:
Main Authors: | Min Hi Park, Ji Young Park, Hye Jin Lee, Dae Hyun Kim, Daeui Park, Hyoung Oh Jeong, Chan Hum Park, Pusoon Chun, Hyung Ryong Moon, Hae Young Chung |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/d41df04f737e4e5584b10e4c0ef5c922 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Artemether Regulates Metaflammation to Improve Glycolipid Metabolism in db/db Mice
by: Fu W, et al.
Published: (2020) -
Renoprotective Effect of Formononetin by Suppressing Smad3 Expression in Db/Db Mice
by: Lv J, et al.
Published: (2020) -
Valsartan alleviates the blood–brain barrier dysfunction in db/db diabetic mice
by: Longxue Cai, et al.
Published: (2021) -
Qihu Preparation Ameliorates Diabetes by Activating the AMPK Signaling Pathway in db/db Mice
by: Zeng H, et al.
Published: (2021) -
Vascular endothelial growth factor-receptor 1 inhibition aggravates diabetic nephropathy through eNOS signaling pathway in db/db mice.
by: Keun Suk Yang, et al.
Published: (2014)